Researchers are developing a two-part therapy for type 1 diabetes: lab-made insulin-producing cells paired with ...

Researchers at UChicago have developed a nanoparticle system that can effectively deliver mRNA to insulin-producing cells, protecting them from the body’s autoimmune response ...

A 42- year-old man with type 1 diabetic begna making his own insulin without daily shots or anti-rejection medication. The breakthrough, published in the New England Journal of Medicine, is being ...

“Although the detailed mechanism for the stimulation of intra-islet GLP-1 secretion remains to be elucidated and further studies are required, as far as we know, our present study is the first to ...

In a recent study published in Nature, researchers report the design and experimental efficacies of NNC2215, a novel insulin conjugate comprising synthetically added glucose-binding macrocycles and ...